Your browser does not support iframes.
N&O 100
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Acadia Pharmaceuticals, Inc.
(NQ:
ACAD
)
14.15
USD
+0.88 (+6.63%)
Official Closing Price
/ Updated:
4:30 PM EDT, May 20, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Acadia Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Bio-Wire Equity Surveillance – Closing Bell 5/20/2013
Today 16:15 EDT
Medium and large sized pharmaceutical companies were down by an average of .3-.6% at the closing bell Jumps by % Gain and Mkt Cap Change Biolife Solutions (OTC: BLFS) +34% on spike in trading activity...
Read More
category
RPTP
,
ACAD
,
MDXG
, and 15 more.
from
Bio-Wire.Com
Biotech Companies See Insider Purchases: CEO Phillip Frost Increases Stake in OPKO and Felix Baker Buys ACADIA
Today 12:20 EDT
Plus, there were purchases at Lionbridge Technologies and LivePerson.
Read More
category
ACAD
,
LPSN
from
Minyanville Headlines
Mid-Morning Market Update: Markets Fall, Yahoo To Acquire Tumblr
Today 10:43 EDT
Following the market opening Monday, the Dow traded down 0.16 percent to 15,329.97, while the NASDAQ fell 0.05 percent to 3,497.34. The S&P was also down, dropping 0.15 percent to 1,664.99. Top...
Read More
category
Earnings
,
Benzinga
,
Movers
, and 17 more.
from
Latest Articles from Benzinga.com
U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
May 18, 2013
Insiders may sell shares for any number of reasons, but conventional wisdom is that insiders really only buy shares of a company for one reason -- they believe the stock price will move higher and they...
Read More
category
GHDX
,
Benzinga
,
Murphy Oil
, and 35 more.
from
Latest Articles from Benzinga.com
StreetInsider.com Pre-Open Movers 5/15: (MFLR) (CHCI) (SPWR) Higher; (XONE) (DE) (P) Lower (more...)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8340361 for the full story.
Read More
from
StreetInsider.com News Articles
Acadia Pharmaceuticals, (ACAD) Prices 8M Share Offering at $12.50/Sh
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8339618 for the full story.
Read More
from
StreetInsider.com News Articles
2 BioPharma Catalyst Trades Set to Break-Out With One Strong Acquisition Target
May 15, 2013
category
Pharmaceuticals
from
Trefis
Streetinsider.com After-Hours Movers 05/14: (MFLR) (TCXX) (VIPS) Higher; (XONE) (RMTI) (ACAD) Lower (more...)
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8338429 for the full story.
Read More
from
StreetInsider.com News Articles
Acadia Pharmaceuticals (ACAD) Announces Stock Offering
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8337102 for the full story.
Read More
from
StreetInsider.com News Articles
ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 14, 2013
ACADIA Pharmaceuticals (NASDAQ: ACAD ) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. There...
Read More
category
Benzinga
,
ACAD
,
Offerings
, and 1 more.
from
Latest Articles from Benzinga.com
KERX, ARIA, PDLI added to BioStock Watch List at GSR
May 14, 2013
from
ACCESSWIRE
StockCall Pre-Market Review on DNDN, SRPT, ACAD, CTIC, and MDVN
May 08, 2013
from
ACCESSWIRE
Needham & Company Maintains Bullish Stance on Acadia (ACAD)
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8316247 for the full story.
Read More
from
StreetInsider.com News Articles
Acadia Pharmaceuticals, Inc. (ACAD) Reports In-Line Q1 Loss
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8313420 for the full story.
Read More
from
StreetInsider.com News Articles
Benzinga Market Primer: Tuesday, May 7
May 07, 2013
Futures Flat Following RBA Rate Cut, European Bank Earnings U.S. equity futures traded near flat following a surprise rate cut from the Reserve Bank of Australia while earnings from three of Europe's...
Read More
category
Earnings
,
China Trade Balance
,
Benzinga
, and 43 more.
from
Latest Articles from Benzinga.com
Jefferies Maintains Bullish Stance on Acadia Pharmaceuticals (ACAD) after Management Meetings
May 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8306115 for the full story.
Read More
from
StreetInsider.com News Articles
Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion
April 29, 2013
Today, we will take a detailed look into a company that has an imminent catalyst, a number of important Phase II and Phase III data releases throughout 2013, and a product pipeline with potential to...
Read More
category
THLD
,
CLDX
,
Scott Matusow
, and 2 more.
from
Bio-Wire.Com
Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion
April 29, 2013
Today, we will take a detailed look into a company that has an imminent catalyst, a number of important Phase II and Phase III data...
Read More
category
investing
,
catalyst trades
,
ACAD
, and 9 more.
from
Bio-Wire.Com
Agenus 8 Near term Data Drivers with a Market Opportunity over $17 Billion dollars
April 29, 2013
category
Pharmaceuticals
from
Trefis
Charting the S&P’s uptrend, and its next hurdle
April 23, 2013
The S&P 500’s uptrend continues to absorb just about anything — sluggish economic data, exogenous events, and a political standstill.
Read More
category
Computer Software
,
Opinion
,
Financial Services
, and 17 more.
from
MarketWatch
ACADIA Listed As Best Performing Biotech
April 22, 2013
Forbes listed ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) as the best performing biotechnology stock over the past 52 weeks lifting the stock price $1.06 to close at $13.15....
Read More
from
MarketMinute.com Stock News
Unusual 11 Mid-Day Movers 04/22: (AIM) (PWER) (MPR) Higher; (AFFX) (MHR) (MEET) Lower
April 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8268288 for the full story.
Read More
from
StreetInsider.com News Articles
Mixed Markets Over Earnings
April 22, 2013
The markets traded mixed during the midday with the Dow losing 35 points to 14,511 while Nasdaq gained 10 points to 3216 as investors digested earnings reports.
Read More
category
Market News
from
MarketMinute.com Market Updates
ACADIA Pharma (ACAD) Moves Higher in Mid-Morning Trading
April 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8267717 for the full story.
Read More
from
StreetInsider.com News Articles
The Best- And Worst-Performing Biotech Stocks, April 12 to April 19
April 20, 2013
These are the best and worst-performing medical and biotech stocks from April 12 to April 19, 2013. This screen includes biotechnology and medical companies traded on the New York Stock Exchange, the...
Read More
category
NASDAQ:THRX
,
NASDAQ:ACAD
,
NASDAQ:SRPT
, and 2 more.
from
Forbes Real Time
Thursday’s BioPharma Trade Movers
April 18, 2013
Today, I have compiled a small list of some biopharmas I feel offer strong upside potential in the short and midterm. Some have event catalysts quickly approaching, while others are strong speculation...
Read More
category
ONXX
,
ATRS
,
SRPT
, and 4 more.
from
Bio-Wire.Com
Thursday’s BioPharma Trade Movers
April 17, 2013
category
Pharmaceuticals
from
Trefis
Bio-Wire Weekly 4/8/13-4/12/13
April 15, 2013
The Newsmakers: April 8-12, 2013 BioCryst Pharmaceuticals (NASDAQ: BCRX) moved significantly higher (~42% by Friday), although it ended the week significantly lower than the highs made on Monday....
Read More
category
QCOR
,
BCRX
,
SRPT
, and 4 more.
from
Bio-Wire.Com
Unexpected Drop In March Retail Sales Weighs Down Markets
April 12, 2013
An unexpected 0.4% drop in March retail sales weighed the markets down to a lower open with the Dow losing 33 points to 14,831. Nasdaq fell 13 points to 3287.
Read More
category
Market News
from
MarketMinute.com Market Updates
Mid-Morning Market Update: Markets Plummet on Bad Data, Rite Aid Continues to Rally
April 12, 2013
Following the market opening Friday, the Dow traded down 0.21 percent to 14,833.98 while the NASDAQ fell 0.40 percent to 3,287.44. The S&P also fell, decreasing 0.47 percent to 1,585.51. Top Headline...
Read More
category
Earnings
,
Benzinga
,
Movers
, and 18 more.
from
Latest Articles from Benzinga.com
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.